Optimum management of invasive cervical cancer in HIV/AIDS patients and impact on survival: Case series from a resource-limited setting and literature review

2016 ◽  
Vol 6 (4) ◽  
pp. 219
Author(s):  
A Adamu ◽  
DA Dawotola ◽  
IM Mohammed ◽  
TA Olasinde
2008 ◽  
Vol 111 (3) ◽  
pp. 555-560 ◽  
Author(s):  
Rene Pareja F. ◽  
Pedro T. Ramirez ◽  
Mauricio Borrero F. ◽  
Gonzalo Angel C.

Author(s):  
Zephania Abraham ◽  
Edwin Thomas ◽  
Aveline Kahinga

Pyoderma gangrenosum (PG) being a primary sterile neutrophilic dermatosis, the etiology is still uncertain and it rarely affects children. A high index of suspicion is essential to execute its prompt treatment. To the best of our knowledge this is the first reported case in our country


2013 ◽  
Vol 8 (1) ◽  
pp. 220 ◽  
Author(s):  
Ziad Fawaz ◽  
Maroie Barkati ◽  
Marie-Claude Beauchemin ◽  
Philippe Sauthier ◽  
Philippe Gauthier ◽  
...  

Vaccine ◽  
2009 ◽  
Vol 27 ◽  
pp. A30-A33 ◽  
Author(s):  
Mario Sideri ◽  
Paolo Cristoforoni ◽  
Chiara Casadio ◽  
Sara Boveri ◽  
Sarah Igidbashian ◽  
...  

2016 ◽  
Vol 26 (8) ◽  
pp. 1490-1496 ◽  
Author(s):  
Caterina Ricci ◽  
Giovanni Scambia ◽  
Rosa De Vincenzo

ObjectiveCervical cancer is the most common gynecological cancer occurring in pregnancy, creating a complex situation both for patient and physician. Neoadjuvant chemotherapy is an innovative way of managing cervical cancer in pregnancy.MethodsIn our paper, we report a retrospective case series of 4 women treated with chemotherapy for invasive cervical cancer during pregnancy in our center over the last 5 years, and we summarize the available literature and guidelines.ResultsAll the cases were locally advanced cervical cancers that received chemotherapy with platinum and/or taxanes. All patients showed a good response to chemotherapy and a radical surgery was performed with no additional morbidities at the cesarean delivery time in 3 of 4 cases. Three of 4 patients are alive and have a good outcome with no recurrence of disease up to date. One patient died because of recurrent disease 2 years after the first-line treatment during pregnancy. All babies are alive and well up to date (maximum follow-up, 63 months).ConclusionsEven if there are no standardized practices in the treatment of cervical cancer in pregnancy, in our opinion, neoadjuvant chemotherapy can be a very useful strategy for patients and physicians facing the challenge.


Sign in / Sign up

Export Citation Format

Share Document